Suppr超能文献

糖尿病是否是 2019 年冠状病毒病(COVID-19)的危险因素?

Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?

机构信息

Department of Clinical and Molecular Medicine, "La Sapienza" University, Via di Grottarossa, 1035-1039, 00189, Rome, Italy.

Endocrine and Metabolic Unit, Sant'Andrea University Hospital, Rome, Italy.

出版信息

Acta Diabetol. 2020 Nov;57(11):1275-1285. doi: 10.1007/s00592-020-01586-6. Epub 2020 Aug 31.

Abstract

The COronaVirus DISease 19 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Older age and presence of comorbidities, including diabetes, were shown to be associated with a more severe course and a higher fatality rate. Studies from the most affected countries, including China, United States and Italy, seem to indicate that prevalence of diabetes among patients affected by COVID-19 is not higher than that observed in the general population, thus suggesting that diabetes is not a risk factor for SARS-CoV-2 infection. However, a large body of evidence demonstrate that diabetes is a risk factor for disease progression towards critical illness, development of acute respiratory distress syndrome, need for mechanical ventilation or admission to intensive care unit, and ultimately death. The mechanisms underlying the relationship between COVID-19 and diabetes remain to be elucidated. In particular, it is still unresolved whether is diabetes per se, especially if poorly controlled, or rather the various comorbidities/complications associated with it that predispose patients with COVID-19 to a worse prognosis. In fact, conditions that cluster with diabetes in the context of the metabolic syndrome, such as obesity and hypertension, or complicate chronic hyperglycemia, such as cardiovascular disease and chronic kidney disease, have also been associated with poor prognosis in these individuals and the available studies have not consistently shown that diabetes predict disease severity independently of them.

摘要

新型冠状病毒病(COVID-19)是一种由新型冠状病毒严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的大流行传染病。年龄较大和存在合并症,包括糖尿病,与更严重的病程和更高的死亡率相关。来自受影响最严重的国家(包括中国、美国和意大利)的研究似乎表明,COVID-19 患者中的糖尿病患病率并不高于普通人群,因此表明糖尿病不是 SARS-CoV-2 感染的危险因素。然而,大量证据表明,糖尿病是疾病向重症进展、急性呼吸窘迫综合征发展、需要机械通气或入住重症监护病房以及最终死亡的危险因素。COVID-19 和糖尿病之间关系的机制仍有待阐明。特别是,目前仍不清楚是糖尿病本身(特别是如果控制不佳),还是与之相关的各种合并症/并发症导致 COVID-19 患者预后较差。事实上,在代谢综合征的背景下与糖尿病聚集的情况,如肥胖症和高血压,或使慢性高血糖复杂化的情况,如心血管疾病和慢性肾病,也与这些个体的不良预后相关,并且现有研究并未一致表明糖尿病独立于这些因素预测疾病严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d54/7456750/a5ae39865027/592_2020_1586_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验